$DRIO
DarioHealth Corp.

2016 Q3 Form 10-Q Financial Statement

#000114420416118094 Filed on August 11, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $728.0K $669.0K $175.0K
YoY Change 166.67% 282.29%
Cost Of Revenue $652.0K $826.0K $410.0K
YoY Change 61.39% 101.46% -32.23%
Gross Profit $76.00K -$157.0K -$235.0K
YoY Change -158.02% -33.19% -61.16%
Gross Profit Margin 10.44% -23.47% -134.29%
Selling, General & Admin $2.140M $1.950M $840.0K
YoY Change 22.29% 132.14% -49.7%
% of Gross Profit 2815.79%
Research & Development $659.0K $521.0K $441.0K
YoY Change -1.2% 18.14% -66.92%
% of Gross Profit 867.11%
Depreciation & Amortization $80.00K $90.00K $80.00K
YoY Change -11.11% 12.5% -50.0%
% of Gross Profit 105.26%
Operating Expenses $2.797M $2.466M $1.277M
YoY Change 15.77% 93.11% -57.4%
Operating Profit -$2.721M -$2.623M -$1.512M
YoY Change 6.83% 73.48% -58.03%
Interest Expense $2.110M -$1.430M -$490.0K
YoY Change 189.04% 191.84% -225.64%
% of Operating Profit
Other Income/Expense, Net $2.110M -$1.434M -$492.0K
YoY Change 193.87% 191.46% -240.97%
Pretax Income -$610.0K -$4.060M -$2.000M
YoY Change -66.67% 103.0% -38.46%
Income Tax
% Of Pretax Income
Net Earnings -$611.0K -$4.057M -$2.004M
YoY Change -66.59% 102.45% -38.41%
Net Earnings / Revenue -83.93% -606.43% -1145.14%
Basic Earnings Per Share -$0.07
Diluted Earnings Per Share -$2.103M -$14.50M -$0.07
COMMON SHARES
Basic Shares Outstanding 5.713M shares 30.24M shares
Diluted Shares Outstanding 30.24M shares

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.600M $6.400M $1.100M
YoY Change 80.0% 481.82% -45.0%
Cash & Equivalents $3.339M $6.376M $981.0K
Short-Term Investments $200.0K $100.0K $100.0K
Other Short-Term Assets
YoY Change
Inventory $1.100M $1.000M $207.0K
Prepaid Expenses
Receivables $300.0K $0.00
Other Receivables $600.0K $300.0K
Total Short-Term Assets $5.600M $8.100M $1.611M
YoY Change 105.81% 402.79% -31.8%
LONG-TERM ASSETS
Property, Plant & Equipment $1.100M $1.000M $854.0K
YoY Change 38.19% 17.1% -13.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets $1.100M $1.000M $894.0K
YoY Change 32.69% 11.86% -14.04%
TOTAL ASSETS
Total Short-Term Assets $5.600M $8.100M $1.611M
Total Long-Term Assets $1.100M $1.000M $894.0K
Total Assets $6.700M $9.100M $2.505M
YoY Change 88.73% 263.27% -26.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $1.000M $900.0K
YoY Change 11.11% 11.11% 28.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.000M $2.000M $1.546M
YoY Change 33.33% 29.37% -12.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.400M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $300.0K $2.000M $4.400M
YoY Change -91.67% -54.55% -18.52%
Total Long-Term Liabilities $300.0K $2.000M $6.800M
YoY Change -95.0% -70.59% 25.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.000M $2.000M $1.546M
Total Long-Term Liabilities $300.0K $2.000M $6.800M
Total Liabilities $2.300M $3.900M $8.300M
YoY Change -69.33% -53.01% 15.28%
SHAREHOLDERS EQUITY
Retained Earnings -$39.85M
YoY Change 51.88%
Common Stock $3.000K
YoY Change 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.400M $5.200M -$5.777M
YoY Change
Total Liabilities & Shareholders Equity $6.700M $9.100M $2.505M
YoY Change 88.73% 263.27% -26.32%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$611.0K -$4.057M -$2.004M
YoY Change -66.59% 102.45% -38.41%
Depreciation, Depletion And Amortization $80.00K $90.00K $80.00K
YoY Change -11.11% 12.5% -50.0%
Cash From Operating Activities -$2.720M -$1.690M -$1.300M
YoY Change 97.1% 30.0% -37.5%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K -$210.0K -$10.00K
YoY Change 700.0% 2000.0% -66.67%
Acquisitions
YoY Change
Other Investing Activities -$150.0K -$10.00K -$10.00K
YoY Change -1600.0% 0.0% -150.0%
Cash From Investing Activities -$310.0K -$220.0K -$20.00K
YoY Change 1450.0% 1000.0% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 20.00K 450.0K
YoY Change -100.0% -95.56% 350.0%
NET CHANGE
Cash From Operating Activities -2.720M -1.690M -1.300M
Cash From Investing Activities -310.0K -220.0K -20.00K
Cash From Financing Activities 0.000 20.00K 450.0K
Net Change In Cash -3.030M -1.890M -870.0K
YoY Change -429.35% 117.24% -56.28%
FREE CASH FLOW
Cash From Operating Activities -$2.720M -$1.690M -$1.300M
Capital Expenditures -$160.0K -$210.0K -$10.00K
Free Cash Flow -$2.560M -$1.480M -$1.290M
YoY Change 88.24% 14.73% -37.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Revenue
CostOfRevenue
707000 USD
us-gaap Gross Profit
GrossProfit
-259000 USD
us-gaap Gross Profit
GrossProfit
-465000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
918000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1324000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1661000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
514000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
986000 USD
us-gaap Operating Expenses
OperatingExpenses
4287000 USD
us-gaap Operating Expenses
OperatingExpenses
2824000 USD
us-gaap Revenues
Revenues
1237000 USD
us-gaap Revenues
Revenues
242000 USD
us-gaap Cost Of Revenue
CostOfRevenue
1496000 USD
drio Stock Issued During Period Value Issued To Officer
StockIssuedDuringPeriodValueIssuedToOfficer
86000 USD
drio Issuance Of Common Stock In January2016 To Service Provider
IssuanceOfCommonStockInJanuary2016ToServiceProvider
37000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
242000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-657000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1512000 USD
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
90000 USD
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
526000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-96000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-2719000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-2004000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2719000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2158000 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.26
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2277000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
376000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
638000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3908000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4363000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3796000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5587800 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1680169 shares
CY2016Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2015Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-5295000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-7142000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
998000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
352000 USD
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
400000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.7
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4644495 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1435873 shares
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
455000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2016Q2 us-gaap Revenues
Revenues
669000 USD
CY2015Q2 us-gaap Revenues
Revenues
175000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
826000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
410000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-157000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
-235000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
521000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
441000 USD
CY2016Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1142000 USD
CY2015Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
262000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
803000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
574000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
2466000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
1277000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2623000 USD
CY2015 drio Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
60000 USD
CY2015 drio Receipts On Account Of Shares
ReceiptsOnAccountOfShares
20000 USD
CY2015 drio Warrants Issued During Period Value In November And December2015
WarrantsIssuedDuringPeriodValueInNovemberAndDecember2015
822000 USD
CY2015 drio Deemed Dividend Inducement Of Warrant Exercise In May2015
DeemedDividendInducementOfWarrantExerciseInMay2015
0 USD
drio Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
210000 USD
CY2015 drio Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
453000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
304000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
193000 USD
CY2015 drio Issuance Of Common Stock In September2015 To Employees Compensation
IssuanceOfCommonStockInSeptember2015ToEmployeesCompensation
591000 USD
CY2015 drio Issuanceof Common Stock In April August And December2015 To Service Provider
IssuanceofCommonStockInAprilAugustAndDecember2015ToServiceProvider
118000 USD
CY2015 drio Stock Issued During Period Value New Issues December2015
StockIssuedDuringPeriodValueNewIssuesDecember2015
500000 USD
CY2015 drio Stock Issued During Period Value New Issues November2015
StockIssuedDuringPeriodValueNewIssuesNovember2015
2294000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
668000 USD
us-gaap Depreciation
Depreciation
163000 USD
us-gaap Depreciation
Depreciation
191000 USD
drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
44000 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2325000 USD
CY2015 drio Stock Issued During Period Value New Issues February2015
StockIssuedDuringPeriodValueNewIssuesFebruary2015
1956000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5038000 USD
CY2015 drio Issuance Of Common Stock In September2015 To Service Provider
IssuanceOfCommonStockInSeptember2015ToServiceProvider
16000 USD
drio Stock Issued During Period Private Placement Value New Issues March2016
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesMarch2016
2500000 USD
drio Deemed Dividend Related To Change In Conversion Term Of Series Preferred Stock Value
DeemedDividendRelatedToChangeInConversionTermOfSeriesPreferredStockValue
0 USD
drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
-84000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
163000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
27000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2832000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3798000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
410000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-245000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-49000 USD
drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
7538000 USD
drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
1956000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7748000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2409000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3705000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-472000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1453000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
981000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
24000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
401000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
246000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000 USD
drio Payment For Executives And Directors Under Salary Program
PaymentForExecutivesAndDirectorsUnderSalaryProgram
102000 USD
drio Payment For Executives And Directors Under Salary Program
PaymentForExecutivesAndDirectorsUnderSalaryProgram
110000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
238000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-163000 USD
us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
-1000 USD
us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
-7000 USD
drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
210000 USD
drio Increase Decrease In Fair Value Of Warrants
IncreaseDecreaseInFairValueOfWarrants
657000 USD
drio Increase Decrease In Fair Value Of Warrants
IncreaseDecreaseInFairValueOfWarrants
-376000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-31000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
54000 USD
CY2016Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
501000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
469000 USD
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
510000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
132000 USD
us-gaap Inventory Write Down
InventoryWriteDown
195000 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
193000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
352000 USD
drio Bank Charges
BankCharges
4000 USD
drio Bank Charges
BankCharges
12000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
27000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
DarioHealth Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001533998
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
DRIO
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5713383 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5688358 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2911788 shares
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0%"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.79in"> <div>NOTE 3:-</div> </td> <td style="TEXT-ALIGN: justify"> <div>UNAUDITED INTERIM FINANCIAL STATEMENTS</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying unaudited interim consolidated financial statements as of June 30, 2016, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of June 30, 2016, and the Company's consolidated results of operations and the Company's consolidated cash flows for the six months ended June 30, 2016. Results for the six months ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
972000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7D
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 drio Deemed Dividend Related To Warrants Exchange Agreement
DeemedDividendRelatedToWarrantsExchangeAgreement
0 USD
CY2015Q2 drio Deemed Dividend Related To Warrants Exchange Agreement
DeemedDividendRelatedToWarrantsExchangeAgreement
154000 USD
drio Deemed Dividend Related To Warrants Exchange Agreement
DeemedDividendRelatedToWarrantsExchangeAgreement
0 USD
drio Deemed Dividend Related To Warrants Exchange Agreement
DeemedDividendRelatedToWarrantsExchangeAgreement
154000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
453000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10000 USD
CY2015 drio Issuance Of Common Stock In July And August2015
IssuanceOfCommonStockInJulyAndAugust2015
5.40
CY2015 drio Issuance Of Common Stock November2015
IssuanceOfCommonStockNovember2015
5.40
CY2015 drio Issuance Of Common Stock December2015
IssuanceOfCommonStockDecember2015
6.16
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
CY2016Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4897994 shares
drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
USD
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2911788 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5688358 shares
CY2015 drio Issuance Of Common Stock And Warrants In February2015
IssuanceOfCommonStockAndWarrantsInFebruary2015
3.24

Files In Submission

Name View Source Status
0001144204-16-118094-index-headers.html Edgar Link pending
0001144204-16-118094-index.html Edgar Link pending
0001144204-16-118094.txt Edgar Link pending
0001144204-16-118094-xbrl.zip Edgar Link pending
drio-20160630.xml Edgar Link completed
drio-20160630.xsd Edgar Link pending
drio-20160630_cal.xml Edgar Link unprocessable
drio-20160630_def.xml Edgar Link unprocessable
drio-20160630_lab.xml Edgar Link unprocessable
drio-20160630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v445666_10q.htm Edgar Link pending
v445666_ex10-2.htm Edgar Link pending
v445666_ex3-1.htm Edgar Link pending
v445666_ex3-2.htm Edgar Link pending
v445666_ex31-1.htm Edgar Link pending
v445666_ex31-2.htm Edgar Link pending
v445666_ex32-1.htm Edgar Link pending
v445666_ex32-2.htm Edgar Link pending